The new trading week kicks off with Novavax (Nasdaq: NVAX). As a clinical-stage biotech, Novavax will be showing more red ink on Monday, and investors know it. The real reason to tune in is to find out how Novavax's pipeline is holding up through the painstakingly slow clinical-trial process.

Novavax was awarded a juicy contract a few weeks ago with the Health and Human Services Department to develop vaccines for the prevention of seasonal and pandemic influenza.

LJ International
(Nasdaq: JADE) and Oxford Industries (NYSE: OXM) report on Tuesday. Between LJ's jewelry and Oxford's apparel, the two companies can combine to dress you up. The other thing that the two have in common is that both companies are expected to post healthy bottom-line growth for the quarter.

Family Dollar
(NYSE: FDO), Acuity Brands (NYSE: AYI), and Verint (Nasdaq: VRNT) are some of the names on Wednesday's reporting calendar. All three companies are also expected to post marked earnings improvement, with enterprise-software specialist Verint in particular reversing a steep year-ago quarterly deficit.

Yuhe Int'l
(Nasdaq: YUII) checks in on Thursday. The Chinese poultry giant isn't chicken about its earnings growth. Analysts expect Yuhe to earn $0.27 a share, just ahead of the $0.23 it rang up a year earlier.

It's quiet on the earnings front, so check the calendar. Yes, it's April 1. If your friend calls you up, asking you to join him for lunch with Warren Buffett, tell him you'll go, but only if you can bring Charlie Munger.

Until next week, I remain,

Rick Munarriz

Follow our Foolish coverage of any of the stocks in this story by adding them to My Watchlist: Novavax, LJ, Oxford, Family Dollar, Acuity, Verint, Yuhe.

The Fool owns shares of Oxford Industries. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

Longtime Fool contributor Rick Munarriz recommends windshield wiper fluid when trying to look forward. He owns no shares in any of the companies in this story and is also part of the Rule Breakers newsletter research team, seeking out tomorrow's ultimate growth stocks a day early. The Fool has a disclosure policy.